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Real-time monitoring of solid-phase peptide
synthesis using a variable bed flow reactor†
Eric T. Sletten, a Manuel Nun˜o, b Duncan Guthrieb and
Peter H. Seeberger *ac
On-resin aggregation and incomplete amide bond formation are
major challenges for solid-phase peptide synthesis that are diﬃcult
to be monitored in real-time. Incorporation of a pressure-based
variable bed flow reactor into an automated solid-phase peptide
synthesizer permitted real-time monitoring of resin swelling to
determine amino acid coupling eﬃciency and on-resin aggregation.
Solid-phase peptide synthesis (SPPS) is carried out using diﬀerent
types of automated peptide synthesis instruments including batch
and continuous-flow (CF) reactors.1–4 CF-SPPS benefits from
increased coupling efficiencies, as a high flux of activated amino
acid increases the relative local excess of reagents when compared
to batch processes (Fig. 1).5–7 In a CF system, the activated amino
acid solution is forced across the resin bed enhancing the reaction
probability while increasing washing efficiency and speed.2,6
A uniform flow of reagents passing a freely swelling resin
results in reliable acylations during CF-SPPS.2 Most automated
CF peptide synthesizers utilize fixed bed reactors that contain
the resin in an arbitrarily set volume.8 The resin volume aﬀects
the coupling by reagent channeling or restricted access by
activated amino acids to the internal polymer matrix. Restric-
tion of resin swelling during peptide elongation can cause back
pressures410 000 psi that leads to resin extrusion and limited
early flow SPPS to tri- and tetrapeptides.2,9,10
Continuous-flow and batch peptide syntheses are currently
followed by in-line UV-vis monitoring of Fmoc cleavage.4,7,11
Thereby, flawed couplings can be detected, but coupling yields
cannot be improved after protecting group removal.
An automated solid-phase peptide synthesizer containing a
variable bed flow reactor (VBFR) can overcome the limitations
Fig. 1 Comparison of solid-phase reactors for automated peptide
synthesis.
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of a fixed bed reactor (Fig. 1). Originally, the reaction was monitored
by measuring the movement of a piston placing a constant
force upon the resin bed.12–15 Since other variables alter these
measurements, pressure fluctuations more accurately correlate with
structural changes of the internal polymer matrix.12 A differential
pressure sensing VBFR was applied to monitor pressure changes
across the reaction bed caused by resin swelling (peptide elongation)
and shrinking (on-resin aggregation and Fmoc removal).16
Autonomous adjustments made to the resin bed size maintain
the pressure while the resin swells freely. The syntheses of
challenging peptides can be monitored and adjustments can
be made for incomplete couplings prior to Fmoc cleavage. We
employed the VBFR technology to optimize the automated
synthesis of various peptides, study the aggregation propensity
of homo- and heteropeptides, and utilize the in-line data to
diagnose and improve the synthesis of challenging peptides.
A single, fully integrated CF peptide synthesizer consists of
an autosampler, two Vapourtec R-seriess pump systems, a
heated preactivation reactor, a VBFR, an in-line UV-vis detector,
and an active backpressure regulator (Fig. 2). The Vapourtec
FlowCommanders software controls the system and records
the UV-vis and VBFR chromatograms in real-time.
Peptide synthesis with the VBFR required three pumps, one
for amino acids and activators, one for the coupling agent, and
an isolated pump for piperidine delivery. Pump A delivered a
nearly saturated solution of Fmoc-protected amino acid (0.24 M)
and HOBt or OxymaPure as coupling agent to loop A, and an
equimolar amount of carbodiimide (DIC) to loop B (loop volumes =
2 mL) was delivered by pump B.17,18
The synthesis of the hydrophobic AFLAFLA sequence served
as a test for the VBFR system to track peptide construction
(Fig. 3).4 During acylation the resin bed volume grows, con-
versely, Fmoc removal contracts the resin. The overall resin bed
volume increase was 0.2 mL. Real-time monitoring helped to
optimize the synthesis cycle (Table S1, ESI†) as four equivalents of
amino acid suﬃced to reach a plateau point for complete coupling.
The VBFR system was compatible with common peptide activators
(HOBt and OxymaPure) and resins (MBHA-RAM and TentaGel-
RAM) for the AFLAFLA synthesis (Table S2, ESI†).2,17
All coupling cycles were performed at elevated temperatures
at a flow rate of 0.7 mL min1. Initially, the coupling reagents
passed through a heated mixing loop (0.8 mL, 80 1C) for
preactivation, then into the VBFR containing the peptidyl resin at
80 1C (Fig. 1). The VBFR system maintained a reactor diﬀerential
pressure of 8 bar (overall system pressure = 10.5 bar) by adjusting
the resin bed volume to ensure precise resin bed packing (see ESI†
for comparative CF reactor pressure study).
Upon coupling cycle completion, pump C delivered a piperidine
solution (10% in DMF) to the resin at a flow rate of 2.7mLmin1 to
cleave the terminal Fmoc, which is monitored by an in-line UV-vis
detector. Interpretation of the UV-vis data requires additional
processing software and time while the plateauing eﬀect of
complete coupling and the sharp decline indicating on-resin
aggregation from the VBFR can be analyzed in real-time.
One synthetic cycle including two wash steps takes 16 min
(Table S1, ESI†). Short reaction cycles requiring low amino acid
equivalents highlights that controlling the resin bed size can
lead to eﬃcient couplings throughout the sequence without
need of a reagent recycling.19
On-resin aggregation by inter- or intramolecular b-sheet
formation causes the peptide to desolvate, thus impeding
further elongations.20 VBFR can detect subtle changes in the
internal polymer network due to pressure fluctuations, such as
on-resin aggregation. Two hydrophobic peptides, oligo-alanine
and oligo-leucine, that have a high aggregation propensity were
synthesized.21–23 Coupling the sixth alanine resulted in a
drastic collapse in the volume of the resin bed as the peptide
formed b-sheets (Fig. 4a). Aggregation of (Ala)6 is consistent
with observations by solid-phase magic angle spinning NMR
and near-infrared Fourier-transform Raman spectroscopy.21,22
A similar resin collapse occurred during the oligo-leucine
synthesis as tightly aggregated resin bed caused a large differ-
ential reactor pressure, which the VBFR system tried to reduce
by rapidly increasing the resin bed volume (Fig. 4a). Exceeding
the overall system pressure limit (18 bar) led to synthesis
termination and the notion that b-sheet interactions of oligo-
leucine may be stronger than in oligo-alanine.
To evaluate the scope of the automated VBFR-SPPS system,
several challenging, biologically relevant peptide sequences
were prepared in good purity and yield (crude yields = 73–84%
and HPLC purities = 79–91%, Fig. 4 and Fig. S4, ESI†).24,25
The amyloidogenic peptide fragment, NFGAIL, previously
required double couplings in eight-fold excess of amino acid.24Fig. 2 Flow diagram of automated VBFR-SPPS.
Fig. 3 Representative chromatogram of the AFLAFLA synthesis (acylation
cycle = blue, Fmoc removal = green; D resin bed volume = red, UV-vis =
black). Further UV data analysis: see ESI.† Areas of rapid resin bed volume
increase are the result of increased flow rates during washing. UV-vis
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Automated VBFR-SPPS of NFGAIL with double couplings of
four equivalent amino acid resulted in constant VBFR resin
bed volume during the second coupling cycle of the initial
leucine (Fig. S4, ESI†) and the subsequent couplings utilized
single cycles. Increases in resin bed volume during coupling
result from peptide elongation and not due to variations in
solvent density. Next, the VBFR synthesis of the FF03, 26-mer
(Fig. S4, ESI†) resulted in an overall resin bed volume change
of 1.5 cm.25 The transferrin receptor binding (TfR) peptide
that contains many differently sized amino acids was synthe-
sized to test the sensitivity of the pressure based VBFR (Fig. S4,
ESI†). While the amino acid residues have similar molecular
weights (330–640 Da), the VBFR system was able to detect the
subtle differences.13
With a VBFR capable of eﬃcient, automated synthesis of
peptides, while monitoring aggregation in hand, we attempted
to reduce the aggregation of the JR10 peptide (Fig. 5).20,26 The
ten amino acid (WFTTLISTIM) peptide required microwave,
fast-flow, or special resins for successful syntheses.3,4
During the initial JR10 construction in DMF, the VBFR
system tracked the aggregation occurring in the coupling of
the leucine residue (Fig. 5a). Upon cleavage from the resin, no
desired product was detected. Aggregation is more apparent in
the VBFR chromatogram when compared to the UV-vis signal
(Fig. S8, ESI†). Aggregation resulted in a broadening of the
dibenzofulvene UV-vis signal during the sixth coupling (D from
fifth coupling = +7%, Fig. S8, ESI†) but no significant variation
was evident until after the seventh coupling (D from sixth
coupling = +115%, Fig. S8, ESI†). The accuracy of the VBFR
can help establish the structural requirements that promote
on-resin peptide aggregation.
We attempted to alleviate on-resin aggregation by several
methods including switching to a more polar solvent to enhance
solubility, lowering resin loading to spread out the elongating
peptides, and using a pseudoproline to disrupt peptide orienta-
tion (Fig. 5).4,20,27 Following the VBFR chromatogram (Fig. 5b
and c), the addition of DMSO and lower loading did help the
construction JR10 peptide through the sixth coupling. These
fixes were only temporary and the aggregation occurred in the
following coupling. Since DMSO oxidizes methionine, lower loading
resin was chosen for further optimization. With aggregation
delayed until the incorporation of threonine, it was substituted
with Fmoc-L-Thr(tBu)-L-Thr[c(Me,Me)Pro]-OH (Fig. 5d). The
VBFR chromatogram indicated continuous growth throughout
the synthesis, with a crude yield of 68% and 71% HPLC purity of
the cleaved mixture.3,4,26 The main impurity was the desired
product containing one t-butyl protecting groups that failed to
cleave.
A variable bed flow reactor system has many advantages for
automated solid-phase peptide synthesis as elongation eﬃciency
and peptide tertiary structure can be monitored in real-time.
Thereby adjustments to a synthesis can be made to preserve amino
acid building blocks. The synthesis of challenging peptides was
optimized by pinpointing the problematic couplings, track on-resin
aggregation, and understand the eﬀects that diﬀerent synthetic
conditions have on peptide sequences. The VBFR systemmaintains
a low overall system pressure throughout peptide syntheses,
such that commercially available resins can be used. Automated
VBFR-SPPS benefits from short synthetic cycle times, requires
only four equivalents of amino acid, and is compatible with
established peptide methodologies.
Fig. 4 (a) Diﬀerence in aggregation properties of oligo-alanine and oligo-leucine. (b) Representative synthesis of a challenging peptide by automated
VBFR-SPPS. D resin bed volume = red, UV-vis = black. See ESI† for further UV-vis data analysis. UV-vis measured at 360 nm.
Fig. 5 Optimization of the JR10 peptide utilizing VBFR. Synthetic conditions:
(a) HOBt, DIC, DMF; (b) HOBt, DIC, 1 : 1 DMF :DMSO; (c) OxymaPure, DIC,
DMF; (d) OxymaPure, DIC, DMF. Resin loading: higher-loading MBHA-RAM =
0.59 mmol g1, lower-loading MBHA-RAM = 0.50 mmol g1. An additional
acetyl-capping step was added after the pseudoproline coupling to prevent
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